Literature DB >> 11411855

Comparison of in vitro activities of amphotericin, clotrimazole, econazole, miconazole, and nystatin against Fusarium oxysporum.

M N Tzatzarakis1, A M Tsatsakis, E Charvalos, D Vakalounakis.   

Abstract

The inhibitory activity of amphotericin B, clotrimazole, econazole, miconazole and nystatin was compared against Fusarium oxysporum f.sp. radicis-cucumerinum. The most efficient antifungal agent against the growth of Fusarium oxysporum was econazole, followed by clotrimazole, miconazole, amphotericin and nystatin. The ED50 and ED90 values were 0.053 and 1.002 ppm for econazole, 0.088 and 1.100 ppm for clotrimazole, 0.173 and 3.210 ppm for miconazole, 0.713 and greater than 48 ppm for amphotericin and 3.860 and 16.702 ppm for nystatin. The ED50 values of nystatin and amphotericin against spore germination of Fusarium oxysporum were determined at 3.1427 ppm and 8.3990 ppm respectively, nystatin was 2.76 times more effective than amphotericin, while no effect was observed after the addition of econazole, clotrimazole and miconazole. The tested azoles were more effective than amphotericin and nystatin on growth inhibition of Fusarium oxysporum but amphotericin and nystatin acted significantly better on spore germination of Fusarium.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11411855     DOI: 10.1081/PFC-100103573

Source DB:  PubMed          Journal:  J Environ Sci Health B        ISSN: 0360-1234            Impact factor:   1.990


  6 in total

Review 1.  Novel paradigms for drug discovery: computational multitarget screening.

Authors:  Ekachai Jenwitheesuk; Jeremy A Horst; Kasey L Rivas; Wesley C Van Voorhis; Ram Samudrala
Journal:  Trends Pharmacol Sci       Date:  2008-01-10       Impact factor: 14.819

2.  Endophthalmitis caused by Fusarium proliferatum.

Authors:  Consuelo Ferrer; Jorge Alio; Alejandra Rodriguez; Mariano Andreu; Francisca Colom
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

Review 3.  Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections.

Authors:  Marit D Moen; Katherine A Lyseng-Williamson; Lesley J Scott
Journal:  Drugs       Date:  2009       Impact factor: 9.546

4.  Antifungal efficacy of voriconazole, itraconazole and amphotericin b in experimental fusarium solani keratitis.

Authors:  Güliz Fatma Yavas; Faruk Oztürk; Tuncay Küsbeci; Zafer Cetinkaya; Sitki Samet Ermis; Nuri Kiraz; Umit Ubeyt Inan
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-10-02       Impact factor: 3.117

5.  Nystatin-intralipid preparation: characterization and in vitro activity against yeasts and molds.

Authors:  R Semis; I Polacheck; E Segal
Journal:  Mycopathologia       Date:  2010-01-13       Impact factor: 2.574

6.  Fusarium proliferatum-induced chronic lip ulcer: successful treatment with itraconazole: a case report.

Authors:  Fatemeh Mohaghegh; Bahareh Abtahi-Naeini; Elahe Nasri; Parisa Badiee; Hamid Morovati; Hamed Fakhim; Aida Farmani; Mohsen Meidani; Maryam Ranjbar-Mobarake; Rasoul Mohammadi
Journal:  J Med Case Rep       Date:  2022-09-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.